Mary Stenson

2.8k total citations
44 papers, 2.2k citations indexed

About

Mary Stenson is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Mary Stenson has authored 44 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 19 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Mary Stenson's work include Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Cutaneous lymphoproliferative disorders research (7 papers). Mary Stenson is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Cutaneous lymphoproliferative disorders research (7 papers). Mary Stenson collaborates with scholars based in United States, Belarus and Greece. Mary Stenson's co-authors include Thomas E. Witzig, Stephen M. Ansell, Anne J. Novak, Zhi‐Zhang Yang, Mamta Gupta, Thomas M. Habermann, Diane F. Jelinek, Linda Wellik, Matthew J. Maurer and Neil E. Kay and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mary Stenson

43 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Stenson United States 23 884 882 743 677 502 44 2.2k
Elaine J. Schattner United States 19 565 0.6× 1.1k 1.2× 665 0.9× 497 0.7× 539 1.1× 31 2.0k
Ryouichi Horie Japan 25 700 0.8× 929 1.1× 565 0.8× 599 0.9× 171 0.3× 73 2.0k
Ewa Lech‐Marańda Poland 25 479 0.5× 437 0.5× 421 0.6× 493 0.7× 511 1.0× 134 1.7k
Mitsuru Tsudo Japan 27 402 0.5× 2.1k 2.4× 862 1.2× 532 0.8× 258 0.5× 75 3.1k
S.A. Johnson United Kingdom 21 587 0.7× 716 0.8× 456 0.6× 411 0.6× 774 1.5× 35 2.0k
Martina Vockerodt Germany 21 751 0.8× 702 0.8× 1.0k 1.4× 643 0.9× 159 0.3× 38 2.2k
Xiao‐Jie Yan United States 28 863 1.0× 1.6k 1.8× 387 0.5× 583 0.9× 1.1k 2.1× 93 2.6k
Roland Grenningloh United States 22 277 0.3× 739 0.8× 259 0.3× 414 0.6× 332 0.7× 39 1.4k
Todd Covey United States 14 487 0.6× 663 0.8× 301 0.4× 318 0.5× 556 1.1× 33 1.4k
Surinder S. Sahota United Kingdom 23 708 0.8× 781 0.9× 497 0.7× 606 0.9× 787 1.6× 61 1.9k

Countries citing papers authored by Mary Stenson

Since Specialization
Citations

This map shows the geographic impact of Mary Stenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Stenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Stenson more than expected).

Fields of papers citing papers by Mary Stenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Stenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Stenson. The network helps show where Mary Stenson may publish in the future.

Co-authorship network of co-authors of Mary Stenson

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Stenson. A scholar is included among the top collaborators of Mary Stenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Stenson. Mary Stenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Kang, Jingjing Han, Mary Stenson, et al.. (2023). Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach. Hematological Oncology. 42(1). e3233–e3233. 1 indexed citations
2.
Wu, Xiaosheng, Mary Stenson, Jithma P. Abeykoon, et al.. (2019). Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma. Blood. 134(4). 363–373. 41 indexed citations
3.
Han, Jing, Megan M. O’Byrne, Mary Stenson, et al.. (2018). Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma. Blood Cancer Journal. 8(11). 110–110. 19 indexed citations
4.
Shenoy, Niraj, Mary Stenson, Joshua D. Lawson, et al.. (2017). Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells. Laboratory Investigation. 97(5). 494–497. 23 indexed citations
5.
Witzig, Thomas E., Craig B. Reeder, Jing Han, et al.. (2015). The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood. 126(3). 328–335. 83 indexed citations
6.
Stenson, Mary, et al.. (2015). The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients?. European Radiology. 25(9). 2682–2687. 60 indexed citations
7.
Gupta, Mamta, Mary Stenson, Megan M. O’Byrne, et al.. (2015). Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma. Annals of Oncology. 27(1). 165–172. 29 indexed citations
8.
Grankvist, Anna, Per‐Ola Andersson, Mattias Mattsson, et al.. (2014). Infections With the Tick-Borne Bacterium "Candidatus Neoehrlichia mikurensis" Mimic Noninfectious Conditions in Patients With B Cell Malignancies or Autoimmune Diseases. Clinical Infectious Diseases. 58(12). 1716–1722. 79 indexed citations
9.
Witzig, Thomas E., Gangqing Hu, Steven M. Offer, et al.. (2013). Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy. Leukemia. 28(1). 147–154. 30 indexed citations
10.
Gupta, Mamta, et al.. (2011). Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy. Leukemia. 26(6). 1356–1364. 105 indexed citations
11.
Ramakrishnan, Vijay, Stephen M. Ansell, Janine Haug, et al.. (2011). MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. Leukemia. 26(2). 340–348. 60 indexed citations
12.
Yang, Zhi-Zhang, Anne J. Novak, Mary Stenson, Thomas E. Witzig, & Stephen M. Ansell. (2005). Intratumoral CD4+CD25+ Regulatory T-Cell-Mediated Suppression of Infiltrating CD4+ T-Cells in B-Cell Non-Hodgkin Lymphoma.. Blood. 106(11). 3312–3312. 13 indexed citations
13.
Ghobrial, Irene M., Daniel McCormick, Scott H. Kaufmann, et al.. (2005). Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood. 105(9). 3722–3730. 114 indexed citations
14.
Ghobrial, Irene M., Nancy D. Bone, Mary Stenson, et al.. (2004). Expression of the Chemokine Receptors CXCR4 and CCR7 and Disease Progression in B-Cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Mayo Clinic Proceedings. 79(3). 318–325. 68 indexed citations
15.
Jelinek, Diane F., Renee C. Tschumper, Susan M. Geyer, et al.. (2001). Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia. British Journal of Haematology. 115(4). 854–861. 164 indexed citations
16.
Ansell, Stephen M., et al.. (1999). Evaluation of the Proliferative Index as a Prognostic Factor in Diffuse Large Cell Lymphoma: Correlation with the International Index. Leukemia & lymphoma. 34(5-6). 529–537. 3 indexed citations
17.
18.
Witzig, Thomas E., Thomas M. Habermann, Paul J. Kurtin, et al.. (1995). S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma. Cancer. 76(6). 1059–1064. 6 indexed citations
19.
Stenson, Mary, et al.. (1994). Effects of Phenylacetate on Cells from Patients with B-Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 14(1-2). 145–149. 11 indexed citations
20.
Witzig, Thomas E., Nick J. Gonchoroff, Philip R. Greipp, et al.. (1989). Rapid S-Phase Determination of Non-Hodgkin’s Lymphomas with the Use of an Immunofluorescence Bromodeoxyuridine Labeling Index Procedure. American Journal of Clinical Pathology. 91(3). 298–301. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine J. Schattner Breakdown of academic impact, for papers by Ryouichi Horie Breakdown of academic impact, for papers by Ewa Lech‐Marańda Breakdown of academic impact, for papers by Mitsuru Tsudo Breakdown of academic impact, for papers by S.A. Johnson Breakdown of academic impact, for papers by Martina Vockerodt Breakdown of academic impact, for papers by Xiao‐Jie Yan Breakdown of academic impact, for papers by Roland Grenningloh Breakdown of academic impact, for papers by Todd Covey Breakdown of academic impact, for papers by Surinder S. Sahota
Rankless by CCL
2026